EVALUATE THE RESULT TREATMENT RADIOTHERAPY THYMUS CANCER AT K HOSPITAL

Văn Long Nguyễn, Lê Huy Trịnh , Công Hoàng Nguyễn

Main Article Content

Abstract

Objecties: Evaluate the results treatment radiotherapy thymus cancer at K hospital. Subjects and Methods: Including 41 thymus cancer patients with surgery stage II, III, IVA. Result: Patients thymus cancer with stage II 36.6% (n = 15), 48.8% (n = 20) stage III, stage IVA 14.6% (n = 6), of which Thymoma type accounts for 73.2% (n = 30), Thymic carcinoma 26.8% (n = 11). The overall non-disease survival rate after 2 years of stage II and III is 100%, in stage IVA is 53.3%. Thymoma type, the overall non-disease survival rate is 100%, Thymic carcinoma type is only 64.3%. Relapse and distant metastasis are seen in the group of IVA patients in Thymic carcinoma type. Conclusion: Phase II, III for the survival rate without disease is 100%, IVA 53.3%. Thymic type is 100%, Thymic carcinoma is 64.3%.

Article Details

References

1. Đặng Ngọc Hùng và Mai Văn Viện (2009), Một số đặc điểm lâm sàng, X-quang và kết quả phẫu thuật cắt bỏ u tuyến ức điều trị bệnh nhược cơ, Y học Việt Nam. 328, tr. 16.
2. Nguyễn Hoàng Gia. Luận văn tốt nghiêp bác sĩ nội trú. Đại họa Y Hà Nội 2015
3. Travis WD Brambilla E, Muller-Hermelink HK, Harris CC (2004), World Health Organization Classification of tumours, Pathology & genetics: Tumours of the lung, pleura, thymus and heart, IARC Press, Lyon, France.
4. Rosenberg Vincent T. DeVita and Steven A. (2015), Cancer-Principles & Practice of Oncology 10th edition, Chaper 43: Neoplasms of theMediastinum, LWW, New York, 10, tr.561-570.
5. Engels E. A. (2010), Epidemiology of thymoma and associated malignancies, J Thorac Oncol. 5(10 Suppl 4), tr. S260-5.
6. Group International Thymic Malignancy Interest (2010), Proceedings of the First International Conference on Thymic Malignancies. August 20-21, 2009. Bethesda, Maryland, USA, J Thorac Oncol. 5(10 Suppl 4), tr. S259-370.
7. Wilkins K. B., Sheikh E., Green R. et al (1999), Clinical and pathologic predictors of survival in patients with thymoma, Ann Surg. 230(4), tr. 562-72; discussion 572-4.
8. Blossom G. B., Ernstoff R. M., Howells G. A. et al (1993), Thymectomy for myasthenia gravis, Arch Surg. 128(8), tr. 855-62.
9. M Uematsu, H Yoshida et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys 1996 May 1;35(2):357-60.
10. Marta Scorsetti, Francesco Leo et al. Thymoma and thymic carcinomas. Crit Rev Oncol Hematol. 2016 mar, 99:332-50